The out-licensing portfolio has been developed to ensure that our customers receive the most comprehensive offer. All the products in the product list of Polpharma Group are carefully selected to ensure that they provide a surplus value for our customers. The product list is based not only on in-house produced APIs but it is also enriched with external licenses.